Moderna (MRNA)
(Delayed Data from NSDQ)
$65.69 USD
-2.33 (-3.43%)
Updated Sep 20, 2024 04:00 PM ET
After-Market: $65.65 -0.04 (-0.06%) 7:58 PM ET
4-Sell of 5 4
F Value C Growth F Momentum F VGM
Cash flow Statements
Fiscal Year End for Moderna, Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | -4,714.00 | 8,362.00 | 12,202.00 | -747.06 | -514.02 |
Depreciation/Amortization & Depletion | 560.00 | 379.00 | 286.00 | 41.44 | 27.28 |
Net Change from Assets/Liabilities | -139.00 | -3,455.00 | 1,308.00 | 2,577.05 | -53.66 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | 1,175.00 | -305.00 | -176.00 | 155.55 | 81.44 |
Net Cash From Operating Activities | -3,118.00 | 4,981.00 | 13,620.00 | 2,026.97 | -458.97 |
Property & Equipment | -707.00 | -400.00 | -284.00 | -67.45 | -31.55 |
Acquisition/ Disposition of Subsidiaries | -85.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | 4,998.00 | -4,776.00 | -8,239.00 | -1,604.48 | 16.61 |
Other Investing Activities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Investing Activities | 4,206.00 | -5,176.00 | -8,523.00 | -1,671.93 | -14.95 |
Uses of Funds
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | -1,107.00 | -3,264.00 | -733.00 | 2,039.41 | 50.15 |
Issuance (Repayment) of Debt | 0.00 | -184.00 | -140.00 | 0.00 | 0.00 |
Increase (Decrease) Short-Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | -270.00 | 0.00 | 0.00 | -6.22 | 0.97 |
Net Cash from Financing Activities | -1,377.00 | -3,448.00 | -873.00 | 2,033.19 | 51.12 |
Effect of Exchange Rate Changes | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Change In Cash & Equivalents | -289.00 | -3,643.00 | 4,224.00 | 2,388.24 | -422.79 |
Cash at Beginning of Period | 3,217.00 | 6,860.00 | 2,636.00 | 247.70 | 670.49 |
Cash at End of Period | 2,928.00 | 3,217.00 | 6,860.00 | 2,635.94 | 247.70 |
Diluted Net EPS | -12.33 | 20.12 | 28.29 | -1.96 | -1.55 |
Fiscal Year End for Moderna, Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | -2,454.00 | -1,175.00 | -4,714.00 | -4,931.00 | -1,301.00 |
Depreciation/Amortization & Depletion | 22.00 | 9.00 | 560.00 | 378.00 | 141.00 |
Net Change from Assets/Liabilities | -86.00 | 60.00 | -139.00 | -388.00 | -570.00 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | 255.00 | 117.00 | 1,175.00 | 1,201.00 | -410.00 |
Net Cash From Operating Activities | -2,263.00 | -989.00 | -3,118.00 | -3,740.00 | -2,140.00 |
Property & Equipment | -378.00 | -196.00 | -707.00 | -487.00 | -347.00 |
Acquisition/ Disposition of Subsidiaries | 0.00 | 0.00 | -85.00 | -85.00 | -85.00 |
Investments | 2,145.00 | 314.00 | 4,998.00 | 5,316.00 | 4,387.00 |
Other Investing Activities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Investing Activities | 1,767.00 | 118.00 | 4,206.00 | 4,744.00 | 3,955.00 |
Uses of Funds
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | 47.00 | 15.00 | -1,107.00 | -1,122.00 | -1,129.00 |
Issuance (Repayment) of Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Increase (Decrease) Short-Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | 1.00 | -1.00 | -270.00 | -146.00 | -81.00 |
Net Cash from Financing Activities | 48.00 | 14.00 | -1,377.00 | -1,268.00 | -1,210.00 |
Effect of Exchange Rate Changes | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Change In Cash & Equivalents | -448.00 | -857.00 | -289.00 | -264.00 | 605.00 |
Cash at Beginning of Period | 2,928.00 | 2,928.00 | 3,217.00 | 3,217.00 | 3,217.00 |
Cash at End of Period | 2,480.00 | 2,071.00 | 2,928.00 | 2,953.00 | 3,822.00 |
Diluted Net EPS | -3.33 | -3.07 | 0.63 | -9.53 | -3.62 |